Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond - King, Lisa A.; Lameris, Roeland; de Gruijl, Tanja D.; van der Vliet, Hans J. (Frontiers in Immunology, 2018)